Health Tech Stocks
Recent market-moving SEC filings and news across health tech companies, ranked by Wiseek's 1–10 importance score.
How Wiseek curates this list
Every item here is a high-importance (score ≥ 7) SEC filing or licensed news event for a health tech company, sourced from SEC EDGAR and licensed news wires and ranked by Wiseek's 1–10 importance score. The underlying source is linked from each article. See our methodology and editorial policy.
Related Healthcare industries
Biotech StocksMedical Device StocksPharmaceutical StocksDiagnostics & Research StocksMedical Instrument StocksHealthcare Facility Stocks
See the full Healthcare sector feed.
Director and 10% Owner Kosasa Thomas Invests $1M in OneMedNet at $0.69/Share
OneMedNet Seeks Shareholder Nod for Reverse Split and Equity Plan Boost to Fend Off Nasdaq Delisting
Alps Group Posts 44% Revenue Growth to $4.9M and a Narrower Loss in Fiscal 2026
Omada Health Swings to Profit in Q2, Revenue Jumps 43%, but Material Weakness Lingers
Claritev Q2 Revenue Beats, but Material Weakness and DOJ Probe Linger
Doximity CEO Says AI Is Unlocking a Bigger Market Than Expected, Shares Surge 34%
Progyny Beats Q2 Estimates, Raises Full-Year Outlook; CEO and Chairman Adopt 10b5-1 Plans
Alps Group Revenue Jumps 44% to $4.9M, Net Loss Narrows in Fiscal 2026
Claritev Tops Q2 Estimates and Lifts Full-Year Outlook on Surging Bookings
Claritev Q2 Revenue, EBITDA Crush Estimates; 2026 Outlook Raised
Doximity Raises FY Outlook, Guides Q2 Above Consensus; Shares Surge 74%
10x Genomics Q2 Revenue Drops 13% as Patent Settlement Windfall Fades; New IP Suits Filed
Nutex Health Q2 Revenue Misses Estimates, Swings to Profit on Cost Cuts
Zhongchao Taps Additional Allocation Option, Selling 454,545 Shares at $1.10
Weave Q2 Revenue Slightly Misses, But Turns Profitable on Non-GAAP Basis
Doximity Q1 profit halves as AI spending surges; $91.6M buyback executed
Progyny Tops Q2 Estimates, Lifts Full-Year Forecast, and Presses Buyback
Health Catalyst Finalizes Vitalware Sale, Pays Off Debt, and Posts Q2 Upside
Weave Q2: Revenue Misses Consensus, Losses Narrow, but Retention Slips
Health Catalyst Closes $147M Vitalware Sale, Pays Off All Debt
Progyny Posts Q2 EPS of 34c, Topping Expectations
Doximity Q1 Profit Halves to $24.3M as AI Spending Surges; Revenue Up 7%
Aclarion's Q2 Loss Deepens to $2.75M, but $10.4M Raise Pushes Cash Runway into H2 2027
Evolent Health Q2 Revenue Jumps 47% on New Performance Suite Contracts, Raises Full-Year Outlook
Privia Health Q2 Revenue Jumps 21% to $633M, Net Income Triples; Credit Facility Doubled to $250M
CareCloud Q2 Revenue Rises 16%, Beats Estimates; Guidance Reaffirmed
CareCloud Reports 16% Revenue Growth in Q2, Reaffirms Full-Year Outlook
Evolent Health Q2 Revenue Jumps 47% to $652.5M, Raises 2026 Guidance, Sees 2027 Adjusted EBITDA ≥$150M
Privia Health Q2 Revenue Surges 21% to $633M, Raises Full-Year Guidance
Privia Health Q2 Revenue Jumps 21%, Raises Full-Year Guidance
HeartBeam Locks In $300K Severance and Full Equity Acceleration for Outgoing CEO
Merger partner Nuclea signs MOU with Utah to explore nuclear test reactor site, advancing microreactor demonstration
Solventum to Spin Off Healthcare Software Unit, Lifts Profit Outlook
Solventum Q2 Earnings Beat Overshadowed by $204M Legal Charge and Health IT Spin-Off Plan
Solventum Q2 Profit Rises, Lifts Full-Year Sales Outlook
GoodRx Q2 Revenue Beats, Raises 2026 Outlook on Pharma Direct Surge
LifeMD Misses Q2 Revenue, Slashes 2026 Guidance on GLP-1 Shift
Schrödinger Inks AI Drug Discovery Deal with Bristol Myers Squibb
Hinge Health Acquires Cylinder Health for $105M, Adding GI Care
Nasdaq Moves to Delist VSee Health, Suspending Trading on August 6